Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritional and branded generic medicines. We develop science-based nutrition products for people of all ages. From helping babies and children grow to keeping adult bodies strong and active to supporting the nutrition needs of people with chronic illnesses, we strive to keep people at their healthiest. We believe that, with good nutrition, every stage of life can be a healthy one.

AbbVie is a highly focused research-driven biopharmaceutical company. AbbVie continues to take bold steps to shape the landscape of inflammatory bowel disease (IBD) management to help patients achieve a better tomorrow.

Albireo Pharma is a clinical-stage biopharmaceutical company focused on development of novel bile acid modulators to treat rare pediatric and adult liver diseases. Albireo’s lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 trials in PFIC, Alagille syndrome and biliary atresia. The Company has initiated a Phase 1 clinical trial for A3907 to advance development in adult cholestatic liver disease, with IND-enabling studies moving ahead with A2342 for viral and cholestatic liver disease. Albireo spun out from AstraZeneca in 2008, headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden.

Ausnutria B.V. is a Dutch dairy company specialized in the development and production of advanced infant nutrition. We are the pioneers behind the world’s leading goat milk based infant formula brand ‘Kabrita’. Goat milk is well known for its easy digestibility, high levels of important nutrients and pleasant mild taste . For Kabrita we combined these natural characteristics of goat milk with advanced formula compositions, based on over 70 years of experience and expertise in infant formula. The result is a full range of gentle goat milk based formulas for every stage, suitable and available for healthy babies and toddlers all around the world.

Biocodex is a French family-owned pharmaceutical company founded in 1953 to develop and market the world’s first probiotic yeast strain, Saccharomyces boulardii CNCM I-745. Today, Biocodex focuses its business on three main areas: its “Microbiota Mission” by educating the general public and healthcare professionals on microbiota, by funding academic research in microbiota and providing solutions for preserving microbiota health; Orphan drugs for patients with severe orphan pathologies around the world, such as DIACOMIT®; Women’s health with the Saforelle brand for women of all ages. With 1,600 employees and 20 subsidiaries, Biocodex generated net revenues of €387 million in 2020. SP-21.09/B

BioGaia is an innovative Swedish healthcare company and has been a world-leader in food supplements with probiotics for 30 years.
Over the years BioGaia has created global networks of leading, independent researchers, manufacturing experts and local distribution partners. BioGaia’s products are recommended by paediatricians and other healthcare professionals in more than 100 countries.
BioGaia’s products contain different strains of the probiotic bacteria Limosilactobacillus reuteri (previously known as Lactobacillus reuteri). More than 200 clinical studies with BioGaia’s strains of L. reuteri have been performed.
BioGaia aims at contributing to improved health by educating people and providing clinically tested and consumer-friendly probiotic products.

Calprotectin is the best marker for IBD diagnosis and therapy follow up in IBD and is useful to support quality of life of children through improved patient management. The easy to use IBDoc® home test that can also be embedded in patient support programmes is a modern element that helps empower children and their parents to manage disease. Another core element by BÜHLMANN to support paediatric patients is the Quantum Blue® rapid test for Infliximab and Adalimumab drug levels and their antibodies. This in combination with control over inflammatory status by calprotectin is the most comprehensive diagnostic solution available today.

Laboratoires CTRS was founded in 2002 to develop, register and market innovative therapies targeted at orphan diseases. The company commercialises a therapy for two ultra-rare bile acid synthesis defects and a product for the treatment of multiple myeloma. CTRS is fully committed to bring new treatments and satisfy unmet medical needs for extremely small patient population with a special focus on liver disorders. It partners with the healthcare community to provide services aimed at improving patients’ standard of care. CTRS has been awarded the prestigious 2014 Prix Galien France and 2016 Prix Galien International for its product Orphacol® (cholic acid).

Lilly is bringing our heritage of championing groundbreaking, novel science to immunology and is driven to change what's possible for people living with autoimmune diseases. To learn more, visit lilly.com.

Eurospital focuses its activities in specific sectors such as in vitro diagnosis of autoimmune disorders, coeliac disease, IBD, as well as detection of genetic predisposition to develop coeliac disease, type 1 diabetes and lactose intolerance.
Actively present worldwide, Eurospital aim is to provide paediatricians, gastroenterologists and laboratory immunologists with highly innovative products for different technologies such as ELISA, turbidimetric, lateral flow and RT-qPCR for antibodies detection, calprotectin determination, coeliacs definition and genetic predisposition determination.

NZMP™ is Fonterra’s global dairy ingredients and solutions brand.  Trusted globally, our broad range of NZMP ingredients are sold in more than 130 countries and can be found at the heart of some of the world’s most famous food and nutrition brands.
SureStart™ is the Paediatric Nutrition ingredients and solutions brand of NZMP™.  We have been at the leading edge of the paediatric nutrition industry for over 60 years, and have a long history of infant formula manufacturing.  Through SureStart™ we deliver high performing ingredients developed through our profound expertise in milk components for paediatric applications.

Royal FrieslandCampina provides millions of consumers throughout the world with nutritious dairy products. FrieslandCampina produces and sells consumer products such as dairy-based beverages, infant nutrition, condensed milk, cheese, and desserts. It supplies cream and butter for professional use and ingredients to the food industry and the pharmaceutical sector. In 2020, annual revenue amounted to EUR 11.1 billion. FrieslandCampina has locations in 38 countries and employs about 23,877 employees. The Central Office is located in Amersfoort, the Netherlands. The company is with over 16,995 member dairy farmers one of the largest dairy cooperatives in the world. For additional information, please visit our website: www.frieslandcampina.com.

FrieslandCampina Ingredients is powered by 2,700 passionate specialists who are focused on adding goodness to the foods, beverages and businesses that nourish the world, now and for generations to come. With its specialised, international market segments Early Life Nutrition, Adult Nutrition and Pharma, FrieslandCampina Ingredients is leading in the food sector as an innovation partner in healthy and functional ingredients and solutions. FrieslandCampina Ingredients operates globally with regional sales offices in the Netherlands, the United States, Singapore, China and Brazil. It reported combined sales of €1.8 billion in 2020. For additional information, please visit: www.frieslandcampinaingredients.com

HiPP is Germany’s leading manufacturer of baby food with a strong focus on organic premium quality. It offers infant, follow-on and growing-up formula, a huge range of complementary feeding, a product range for pregnant and breastfeeding women and also provides baby care cosmetics. The company is a family-run business which was founded in 1932 and is based in Pfaffenhofen, Bavaria, Germany. HiPP products are exported to more than 60 countries worldwide. https://hcp.hipp.com/

At IFF Health, our goal is to provide scientifically proven ingredients to support a healthy start for our youngest kids. We recognize that the first 1000 days, from conception to two years of age, is a critical time for the establishment of a healthy microbiome and immune system. Our ingredients are studied in infant and young children and demonstrated to promote health in areas such as:

• Digestive health
• Immune health
• Microbiome development

Contact us to learn more our early life nutrition portfolio, including CARE4U™ HMO, Litesse® fiber and our full line of HOWARU® Probiotics, including our newest strain, HOWARU Lp-202195™.

The Mead Johnson Pediatric Nutrition Institute—part of Reckitt—relentlessly pursues a healthier world by working closely with global experts to advance nutrition science and share it with Healthcare Professionals who can use it to make a real difference for their patients. With our global network of research and development scientists, research laboratories and facilities that put us at the forefront of pediatric nutrition science, we continue to build upon decades of innovation and collaboration to positively impact the future. MJPNI puts Reckitt’s purpose to protect, heal and nurture into practice through shared success with our partners.

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating liver diseases. Mirum’s lead product candidate, maralixibat, is an investigational oral drug in development for ALGS, PFIC, and biliary atresia. Mirum has submitted an NDA for maralixibat in the treatment of cholestatic pruritus in patients with ALGS. Additionally, Mirum’s marketing authorization application for the treatment of pediatric patients with PFIC2 has been accepted for review by the European Medicines Agency. Mirum is also developing volixibat, another oral ASBT-inhibitor, in primary sclerosing cholangitis, intrahepatic cholestasis of pregnancy, and primary biliary cholangitis.

Nestlé helps the next generation of children to develop their full potential and live healthier lives by providing high quality, innovative, science-proven nutrition solutions and education for mothers and infants in the crucial first 1000 Days’ of life.
The Nestlé Nutrition Institute (NNI) is a non for profit association in Switzerland that exists to advance and disseminate the science in nutrition. All exclusive resources are available at http://www.nestlenutrition-institute.org

Nestlé Health Science is a leader in the science of nutrition, committed to redefining the management of health.  From babies to the most senior citizens, we offer solutions to fill nutrition gaps, nourish those who need extra care and provide innovative products for a healthier future across the spectrum of life.  We believe in empowering healthier lives through nutrition.  Our extensive research network, both within Nestlé’s R&D centers as well as with external partners, provides the foundation for products that can help people to live their healthiest lives.

Since 1896, Nutricia has pioneered nutritional solutions that help people live longer, more joyful and healthier lives. Building on more than a century of research and innovation, Nutricia has harnessed the power of life-changing and life-saving nutrition to create a leading specialized nutrition portfolio that can change a health trajectory for life.
With its nutritional solutions, Nutricia supports healthy growth and development during the first 1000 days and helps to address some of the world’s biggest health challenges; pre-term birth, faltering growth and food allergy.

The Rome Foundation is an independent not-for-profit organization dedicated to supporting the creation of scientific data and educational information to assist in diagnosing and treating Disorders of Gut-Brain Interaction (DGBIs), formerly called Functional Gastrointestinal Disorders (FGIDs).

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. www.takeda.com

Thermo Fisher Scientific is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. Our complete blood test systems support the clinical diagnosis of allergy, asthma and autoimmune diseases. With employees worldwide in ImmunoDiagnostics, we are a global leader in in-vitro allergy diagnostics and a European leader in autoimmunity diagnostics. The allergy and autoimmunity product lines operate on a common automated instrument platform, which supports both productivity and cost efficiencies in clinical laboratories around the world.

TNO drives biomedical, technological and social innovations in collaboration with knowledge institutes, public and private partners and government authorities. Multidisciplinary teams of top scientists and technical experts enable us to model, mimic and measure infant health and disease risk.
We believe the 1st 1000 days to be crucial for adequate development and long-term health outcomes. Therefore our programs include parental guidance around conception, pregnancy, nutrition and child development. Moreover, we connect experimental and clinical studies with innovative technologies to identify biomarkers for health and disease, as well as substantiate the health benefit of compounds. TNO has a broad international network and reputation as valuable and trusted research partner.

vaneeghen is a family-owned company with more than 350 years of experience in the production and distribution of food-related items. Over the years, we have evolved into a leading international distributor of innovative products, vitamins, plant extracts, minerals, and other nutrients.
Throughout our long history, crucial factors in our success have been our reliability, flexibility, and extremely high level of service – and they remain so today. Along with our outstanding ingredients and nutraceuticals, these core values help us to establish relationships with our customers that are valuable and long-lasting.

For the past 100 years, Wyeth Nutrition has pioneered innovative nutrition science with premium-quality products that meet the needs of infants, young children, and adults. Through clinical rigor, scientific research, world-class manufacturing, and product safety standards, we deliver scientifically sound solutions that offer parents confidence to help nourish children and support healthy futures, when breastfeeding is not an option. By partnering with mothers, doctors, and scientists, we continue to discover and learn what is needed to ensure the best advancement for the health and well-being of future generations.